Xaira Therapeutics today announced the appointment of Dr. Bo Wang as SVP and Head of Biomedical AI. In this role, Dr. Wang will lead the company's efforts to develop AI-driven models to help elucidate ...

Rahman discusses Google Gemini and what it could mean to the future of pharma commercialization and content development.

The Global AI in Precision Medicine Market is expected to witness a growth rate of 25-30% in the next five years.

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

According to Dealroom, in Q1 2025, European startups have secured $15.8B through nearly 1,600 funding rounds. From AI and fintech to clean energy and biotech, startups have attracted large amounts of ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...

Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.

The latest health updates include the FDA's approval of a new freeze-dried mpox vaccine, and a judge's dismissal of a $10 ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...